PRKCD and hepatocellular carcinoma: Besides, IQGAP3 can also bind to protein kinase Cδ (PKCδ) to competitively inhibit the interaction between PKCδ and PKCα, allowing PKCα release, and activate PI3K/AKT signaling pathways to promote HCC cell proliferation [22].